Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma.
Pharmacotherapy
; 32(7): 596-603, 2012 Jul.
Article
in En
| MEDLINE
| ID: mdl-22760691
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Hematopoietic Stem Cell Mobilization
/
Peripheral Blood Stem Cell Transplantation
/
Heterocyclic Compounds
/
Multiple Myeloma
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Pharmacotherapy
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United States